Charles Schwab Investment Management Inc. Acquires 9,004 Shares of Amedisys, Inc. (NASDAQ:AMED)

Charles Schwab Investment Management Inc. increased its holdings in Amedisys, Inc. (NASDAQ:AMED) by 2.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 346,082 shares of the health services provider’s stock after purchasing an additional 9,004 shares during the quarter. Charles Schwab Investment Management Inc. owned approximately 1.06% of Amedisys worth $33,400,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of AMED. Arizona State Retirement System boosted its position in Amedisys by 2.0% during the second quarter. Arizona State Retirement System now owns 9,145 shares of the health services provider’s stock valued at $840,000 after acquiring an additional 177 shares during the last quarter. Signaturefd LLC boosted its position in Amedisys by 20.9% during the third quarter. Signaturefd LLC now owns 1,367 shares of the health services provider’s stock valued at $132,000 after acquiring an additional 236 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Amedisys by 0.8% during the first quarter. Price T Rowe Associates Inc. MD now owns 31,199 shares of the health services provider’s stock valued at $2,876,000 after acquiring an additional 255 shares during the last quarter. State of Alaska Department of Revenue boosted its position in Amedisys by 7.2% during the third quarter. State of Alaska Department of Revenue now owns 3,782 shares of the health services provider’s stock valued at $365,000 after acquiring an additional 255 shares during the last quarter. Finally, CWM LLC boosted its position in Amedisys by 14.5% during the third quarter. CWM LLC now owns 2,190 shares of the health services provider’s stock valued at $211,000 after acquiring an additional 277 shares during the last quarter. Institutional investors own 94.36% of the company’s stock.

Amedisys Price Performance

AMED stock opened at $86.27 on Wednesday. The stock has a market capitalization of $2.83 billion, a PE ratio of 34.23, a price-to-earnings-growth ratio of 1.92 and a beta of 0.73. The company’s 50-day moving average is $94.63 and its 200-day moving average is $95.59. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.19 and a quick ratio of 1.19. Amedisys, Inc. has a 1 year low of $85.84 and a 1 year high of $98.95.

Amedisys (NASDAQ:AMED) last released its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $587.67 million for the quarter, compared to the consensus estimate of $586.75 million. During the same period last year, the company earned $0.98 EPS. Amedisys’s revenue for the quarter was up 5.7% compared to the same quarter last year. Equities research analysts expect that Amedisys, Inc. will post 4.53 EPS for the current fiscal year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.